|
Independent research & practical ideas for global prosperity
|
|
|
|
Independent research & practical ideas for global prosperity
|
|
 Saving Lives by Counting DeathsFebruary 6, 2012By Kate McQueston in Evaluation, Monitoring, and Measurement, Global Health, Malaria Tags: Malaria
A recent study from the Lancet says that malaria caused 1.24 million deaths in 2010 (compared to previous estimates of 655,000), suggesting that the number of deaths from malaria globally may be twice as large as previously believed. Needless to say, this new finding is making headlines and bringing renewed attention to malaria as a central focus of global health efforts. 1 Comment »Sound Bites from PopPovJanuary 27, 2012By Kate McQueston in Global Health, Population & Reproductive Health Tags: Population
Total fertility has been decreasing in many African countries—from 5.9 in 2001 to 4.6 in 2009 in Ethiopia and 5.5 in 2001 to 4.9 in 2009 in Senegal, though still high in comparison to many parts of the world (for more data on total fertility trends see here). This decline has come with both health benefits and development opportunities, but there is still a great need for improved population policies. Luckily, the field of research covering the economic and demographic responses to reproductive health interventions, as well as other fertility related factors, has developed into a vibrant and growing community over the last decade. Last week these individuals got together at the 6th annual PopPov conference in Accra, Ghana—bringing together economists, demographers, sociologists and public health experts from all over the world. To learn more, check out a new informational video on the PopPov’s homepage. Comment »Top 20 Posts of 2011 from CGD’s Global Health Policy BlogDecember 21, 2011By Kate McQueston in Global Health Tags: Global Health
It’s the time of year for “top” lists. At the CGD Global Health Policy Blog, we have decided yet again to highlight a combination of CGD’s and our reader’s favorite 20 blog posts from this year. This year we celebrated the financial success of GAVI, and documented the troubles of the WHO and the Global Fund. We thought about new ways to address the HIV epidemic, analyzed the role of middle-income countries in global health, and looked at new methods for allocating health resources. We’ve covered everything from the NCD summit to the evolution of the GHI. Here’s to another year of great blogging! Comment »The Ethics of Inaction: Releasing the Bottleneck on Clinical TrialsNovember 2, 2011By Kate McQueston in Evaluation, Monitoring, and Measurement, Global Health Tags: Clinical Trials, Global Health
Like most things, ethical considerations for clinical trials can produce both positive and negative results. The positives, of course, include protecting the rights, safety, and well-being of trial participants. And the negatives? Aside from the financial costs associated with review (which can be substantial), current systems to ‘promote’ ethical considerations are often overly complicated and slow. And at times, the system of ethical roadblocks, regulations, and bureaucracy for clinical trials procedures can be so restrictive that it actually prevents patients from receiving beneficial treatments within an reasonable period of time. Comment »Not Too Late to Ride the Hype: USAID and NCDsSeptember 22, 2011By Kate McQueston in NCDs, Uncategorized Tags: Global Health Initiative, NCDs, USAID
This is a joint post with Amanda Glassman. Everyone seems to be throwing their hat into the ring in the battle against non-communicable disease (NCD), from George W. Bush to Lance Armstrong. Now it appears USAID has entered the mix as well. Despite the agency’s absence from a CGD sponsored panel discussion last week, the USAID communications department is shifting into full gear—implying that they plan to join the fight after all. 1 Comment »Drug Resistance: Coming Soon to a Neighborhood Near YouAugust 10, 2011By Kate McQueston in Drug Resistance Tags: Drug Resistance
This spring the WHO kicked off World Health Day with a foreboding slogan, “Antimicrobial resistance: no action today, no cure tomorrow,” to increase awareness of the dangers of drug resistance. Two months later, a new strand of E coli:0104 rapidly spread throughout thirteen countries in Europe and proved resistant to more than a dozen antibiotics. Considering these two events, policy makers and health care providers should be moving faster to set drug resistance as a top priority. 2 Comments »
|
|
|
|
CENTER FOR GLOBAL DEVELOPMENT
1800 Massachusetts Avenue NW, Third Floor
Washington DC 20036
Tel 202.416.4000 | Fax 202.416.4050
|
|
|
Print
Share
